Your account has not been permission, data will display ***. Please Upgrade to use. Close notice
Hướng dẫn sử dụng

Dak Lak Pharmaceutical Midecal Equipment JSC (UPCoM: DBM)

29,300

(%)
04/26/2024 15:25

Open29,300

High29,300

Low29,300

Vol1

Market Cap.56.89

Remain Bid799

Remain Ask3,799

52Wk High37,000

52Wk Low25,000

52Wk Avg Vol147

Foreign Buy-

Frgn Owned(%)23.01

Dividend1,700

Dividend Yield0.06

Beta-0.28

EPS2,895

P/E10.12

F P/E9.48

BVPS24,723

P/B1.19

Financial ratios of latest trading date, EPS in the company's latest quarter Financial Statement
View with DBM: BCP CLG CNC ACB MKV
Trending: HPG (72,774) - NVL (61,532) - DIG (60,656) - VND (51,835) - MBB (48,744)
1 day | 5 day | 3 months | 6 months | 12 months
- DakLak Pharmaceutical Medical Equipment Joint Stock Company (DBM), formerly known as Daklak Pharmaceutical Company ,was established in 1976. DBM has come into operation under the model of a joint stock company since 2003. The company has its business in distribution of pharmaceutical products and medical equipments. DBM's business areas are located mainly in Dak Lak and Dak Nong. DBM has beent traded on the UPCOM m... View more
DateCloseChangeVolume
04/26/202429,3000 (0.00%)1
04/25/202429,3003,800 (+14.90%)307
04/24/202425,5000 (0.00%)0
04/23/202425,5000 (0.00%)0
04/22/202425,5000 (0.00%)0
Volume: share, Price: Dong
Unit: Million Dong
Unit: Million Dong
06/08/2023DBM Dividend payment in cash with 17.00% for 2022 (Record date)
06/08/2023DBM Dividend payment in cash with 17.00% for 2022
06/09/2022DBM Dividend payment in cash with 17.00% for 2021
06/09/2022DBM Dividend payment in cash with 17.00% for 2021 (Record date)
06/14/2021DBM Dividend payment in cash with 5.00% (Tranche 2/2020) (Record date)
04/23/2024Resolution of Annual Shareholders' Meeting 2024
04/02/20242024 Annual Shareholders’Meeting Documents
03/12/2024Annual report 2023
03/07/2024Audited FS 2023
01/18/2024 Corporate Governance Report 2023

Dak Lak Pharmaceutical Midecal Equipment JSC

Name: Dak Lak Pharmaceutical Midecal Equipment JSC

Abbreviation:BAMEPHARM

Address: 9A Hung Vuong Street, Tu An Ward Buon Ma Thuot Dak Lak

Telephone: (84.262) 381 2394 - 391 7118

Fax: (84.262) 385 8805

Email:bamepharm@yahoo.com

Website:https://bamepharm.com.vn

Exchange: UPCoM

Sector: Manufacturing

Industry: Chemical - Pharmaceutical

Listing date: 12/17/2009

Chartered capital: 19,415,880,000

Listed shares: 1,941,588

Shares outstanding: 1,941,584

Status: Operating

Tax code: 6000449389

Establishment license: 28/QÐ-TC

Issued date: 04/14/1976

Business license: 4003000036

Issued date: 04/25/2008

Main business scope:

- Trading drugs, pharmaceuticals, vaccines, biological medicial products and laboratory chemicals.

- Trading, exporting and importing drugs, pharmaceuticals and medical equipments.

- Maintaining and repairing medical equipments.

- Others under the business registration certificate.

- April 14, 1976: Formerly known as Dak Lak Pharmaceutical Company was established under the Decision No.28/QD-TC issued by Dak Lak Revolutional People's Committee;

- August 02, 1982: Renamed as Dak Lak Pharmaceutical Union Enterprise under the Decision No.358/QD-UB issued by Dak Lak Provincial People's Committee;

- December 21, 1982: Renamed as Dak Lak Pharmaceutical Medical Equipment Company;

- 2003: Equitized and transformed into Dak Lak Pharmaceutical Medical Equipment Joint Stock Company;

- December 17, 2009: Traded on the UPCOM market;

- 2012: 51% of SCIC shareholder was transfered to Traphaco Joint Stock Company;

ItemsUnit
PriceVND
VolumeShares
Foreigner's, Yield%
Mkt CapbVND
Financial indicatorsmVND
EPS, BVPS, DividendVND
P/E, F P/E, P/BTimes
ROS, ROA, ROE%
1. The accounting period for the equitization year is defined as of the company's establishment date.
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
* Vietstock tổng hợp thông tin từ các nguồn đáng tin cậy vào thời điểm công bố cho mục đích cung cấp thông tin tham khảo. Vietstock không chịu trách nhiệm đối với bất kỳ kết quả nào từ việc sử dụng các thông tin này.